Columbia Care IncChange company Symbol lookupSelect an option...CCHWF Columbia Care IncFRME First Merchants CorpV Visa IncVRAY ViewRay IncLLAP Terran Orbital CorpRTX Raytheon Technologies CorpPLUG Plug Power IncPNM PNM Resources IncPFE Pfizer IncNIO NIO IncGo
Change company Symbol lookup
Select an option...
CCHWF Columbia Care Inc
FRME First Merchants Corp
V Visa Inc
VRAY ViewRay Inc
LLAP Terran Orbital Corp
RTX Raytheon Technologies Corp
PLUG Plug Power Inc
PNM PNM Resources Inc
PFE Pfizer Inc
NIO NIO Inc
Health Care : Pharmaceuticals | Small Cap Growth
Company profileColumbia Care Inc. is a cultivator, manufacturer and provider of cannabis products and related services. The Company’s principal business activity is the production and sale of cannabis. The Company operates approximately 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities. The Company offers products such as spanning flower, edibles, oils, and tablets. It manufactures brands which include Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label Cannabidiol (CBD). The Company, through its subsidiaries, owns or manages interests in state-licensed medical and/or adult use marijuana businesses in Arizona, California, Colorado, Delaware, European Union, Florida, Illinois, Maryland, Massachusetts, Missouri, New Jersey, New York and Puerto Rico, among others. The Company’s subsidiaries include 203 Organix, L.L.C., Columbia Care - Arizona, Tempe, L.L.C., Columbia Care-Arizona, Prescott, L.L.C. and Salubrious Wellness Clinic, Inc.
|
|
|
|
| |
| Latest Earnings Met Consensus (Q3 ending 09/2022) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q3 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced November 14, 2022 | -$0.09 | Q3 Estimate range of 6 analysts | -$0.13 to -$0.05 | Q4 Earnings will announce | (Unconfirmed) March 15, 2023 |
Quarterly Earnings History and Estimates
Hide high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
CCHWF's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.